Airway management

Ketamine versus etomidate as an induction agent for tracheal intubation in critically ill adults: a Bayesian meta-analysis

Crit CarePublished Systematic review and Bayesian meta-analysis of randomised trials and matched observational studies

Pooled resultResult — go to the resultRelative risk 0.93 95% CrI 0.79–1.08

Authors' conclusion

This meta-analysis showed a moderate probability that induction with ketamine is associated with a reduced risk of mortality.

Study context

Population
Critically ill adults undergoing tracheal intubation7 RCTs, 1 propensity-matched study
Participants
2,978 adults
Comparison
Ketamine vs etomidate as induction agent for tracheal intubation
  • Ketaminen = 1,475
  • Etomidaten = 1,503reference
Outcome
Mortality at the longest follow-up available
Methodological detailsBayesian random-effects, weakly informative neutral prior
  • Bayesian random-effects
  • Weakly informative neutral prior

Pooled result

As reported in the abstract

Relative risk

0.93

95% CrI 0.79–1.08

Events by group

Ketamine vs Etomidate
RR 0.93 (95% CrI 0.79–1.08)

Further pooled results

SOFA score, ventilator-free days, vasopressor-free days, post-induction MAP, first-attempt intubation success

No significant difference in any secondary outcome

Original publication

Ketamine versus etomidate as an induction agent for tracheal intubation in critically ill adults: a Bayesian meta-analysis. Crit Care. Published 17 February 2024. doi:10.1186/s13054-024-04831-4

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.